Cargando…

Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine

BACKGROUNDS: Dyslipidemia is a prominent risk factor for cardiovascular diseases and one of the primary independent modifiable factors of diabetes and stroke. Statins can significantly improve the prognosis of dyslipidemia, but its side effects cannot be ignored. Traditional Chinese Medicine (TCM) h...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinlei, Dan, Wenchao, Liu, Xudong, Zhong, Xiaoxue, Chen, Cheng, He, Qingyong, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079798/
https://www.ncbi.nlm.nih.gov/pubmed/37035723
http://dx.doi.org/10.1007/s13755-023-00215-0
_version_ 1785020785106092032
author Liu, Jinlei
Dan, Wenchao
Liu, Xudong
Zhong, Xiaoxue
Chen, Cheng
He, Qingyong
Wang, Jie
author_facet Liu, Jinlei
Dan, Wenchao
Liu, Xudong
Zhong, Xiaoxue
Chen, Cheng
He, Qingyong
Wang, Jie
author_sort Liu, Jinlei
collection PubMed
description BACKGROUNDS: Dyslipidemia is a prominent risk factor for cardiovascular diseases and one of the primary independent modifiable factors of diabetes and stroke. Statins can significantly improve the prognosis of dyslipidemia, but its side effects cannot be ignored. Traditional Chinese Medicine (TCM) has been used in clinical practice for more than 2000 years in China and has certain traits in treating dyslipidemia with little side effect. Previous research has shown that Mutual Obstruction of Phlegm and Stasis (MOPS) is the most common dyslipidemia type classified in TCM. However, how to compose diagnostic factors in TCM into diagnostic rules relies heavily on the doctor's experience, falling short in standardization and objectiveness. This is a limit for TCM to play its advantages of treating dyslipidemia with MOPS. METHODS: In this study, the syndrome diagnosis in TCM was transformed into the prediction and classification problem in artificial intelligence The deep learning method was employed to build the classification prediction models for dyslipidemia. The models were built and trained with a large amount of multi-centered clinical data on MOPS. The optimal model was screened out by evaluating the performance of prediction models through loss, accuracy, precision, recall, confusion matrix, PR and ROC curve (including AUC). RESULTS: A total of 20 models were constructed through the deep learning method. All of them performed well in the prediction of dyslipidemia with MOPS. The model-11 is the optimal model. The evaluation indicators of model-11 are as follows: The true positive (TP), false positive (FP), true negative (TN) and false negative (FN) are 51, 15, 129, and 9, respectively. The loss is 0.3241, accuracy is 0.8672, precision is 0.7138, recall is 0.8286, and the AUC is 0.9268. After screening through 89 diagnostic factors of TCM, we identified 36 significant diagnosis factors for dyslipidemia with MOPS. The most outstanding diagnostic factors from the importance were dark purple tongue, slippery pulse and slimy fur, etc. CONCLUSIONS: This study successfully developed a well-performing classification prediction model for dyslipidemia with MOPS, transforming the syndrome diagnosis problem in TCM into a prediction and classification problem in artificial intelligence. Patients with dyslipidemia of MOPS can be accurately recognized through limited information from patients. We also screened out significant diagnostic factors for composing diagnostic rules of dyslipidemia with MOPS. The study is an avant-garde attempt at introducing the deep-learning method into the research of TCM, which provides a useful reference for the extension of deep learning method to other diseases and the construction of disease diagnosis model in TCM, contributing to the standardization and objectiveness of TCM diagnosis.
format Online
Article
Text
id pubmed-10079798
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100797982023-04-08 Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine Liu, Jinlei Dan, Wenchao Liu, Xudong Zhong, Xiaoxue Chen, Cheng He, Qingyong Wang, Jie Health Inf Sci Syst Research BACKGROUNDS: Dyslipidemia is a prominent risk factor for cardiovascular diseases and one of the primary independent modifiable factors of diabetes and stroke. Statins can significantly improve the prognosis of dyslipidemia, but its side effects cannot be ignored. Traditional Chinese Medicine (TCM) has been used in clinical practice for more than 2000 years in China and has certain traits in treating dyslipidemia with little side effect. Previous research has shown that Mutual Obstruction of Phlegm and Stasis (MOPS) is the most common dyslipidemia type classified in TCM. However, how to compose diagnostic factors in TCM into diagnostic rules relies heavily on the doctor's experience, falling short in standardization and objectiveness. This is a limit for TCM to play its advantages of treating dyslipidemia with MOPS. METHODS: In this study, the syndrome diagnosis in TCM was transformed into the prediction and classification problem in artificial intelligence The deep learning method was employed to build the classification prediction models for dyslipidemia. The models were built and trained with a large amount of multi-centered clinical data on MOPS. The optimal model was screened out by evaluating the performance of prediction models through loss, accuracy, precision, recall, confusion matrix, PR and ROC curve (including AUC). RESULTS: A total of 20 models were constructed through the deep learning method. All of them performed well in the prediction of dyslipidemia with MOPS. The model-11 is the optimal model. The evaluation indicators of model-11 are as follows: The true positive (TP), false positive (FP), true negative (TN) and false negative (FN) are 51, 15, 129, and 9, respectively. The loss is 0.3241, accuracy is 0.8672, precision is 0.7138, recall is 0.8286, and the AUC is 0.9268. After screening through 89 diagnostic factors of TCM, we identified 36 significant diagnosis factors for dyslipidemia with MOPS. The most outstanding diagnostic factors from the importance were dark purple tongue, slippery pulse and slimy fur, etc. CONCLUSIONS: This study successfully developed a well-performing classification prediction model for dyslipidemia with MOPS, transforming the syndrome diagnosis problem in TCM into a prediction and classification problem in artificial intelligence. Patients with dyslipidemia of MOPS can be accurately recognized through limited information from patients. We also screened out significant diagnostic factors for composing diagnostic rules of dyslipidemia with MOPS. The study is an avant-garde attempt at introducing the deep-learning method into the research of TCM, which provides a useful reference for the extension of deep learning method to other diseases and the construction of disease diagnosis model in TCM, contributing to the standardization and objectiveness of TCM diagnosis. Springer International Publishing 2023-04-06 /pmc/articles/PMC10079798/ /pubmed/37035723 http://dx.doi.org/10.1007/s13755-023-00215-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Liu, Jinlei
Dan, Wenchao
Liu, Xudong
Zhong, Xiaoxue
Chen, Cheng
He, Qingyong
Wang, Jie
Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title_full Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title_fullStr Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title_full_unstemmed Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title_short Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine
title_sort development and validation of predictive model based on deep learning method for classification of dyslipidemia in chinese medicine
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079798/
https://www.ncbi.nlm.nih.gov/pubmed/37035723
http://dx.doi.org/10.1007/s13755-023-00215-0
work_keys_str_mv AT liujinlei developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT danwenchao developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT liuxudong developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT zhongxiaoxue developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT chencheng developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT heqingyong developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine
AT wangjie developmentandvalidationofpredictivemodelbasedondeeplearningmethodforclassificationofdyslipidemiainchinesemedicine